Thought leadership

At Langland, we don’t just appreciate individuality – we encourage it. Our work is the creation of many unique perspectives, coming together to create something greater than the sum of its parts.

Don’t take our word for it – take a look at the ideas, perspectives and expert thought leadership of the many minds of Langland.

Effective communications are the lifeblood of clinical research

January 29, 2026

Effective communications are the lifeblood of clinical research

Clinical trials can be thought of as living, breathing systems – intricate networks of patients, caregivers, investigators, site staff and sponsors working towards a shared ambition: advancing medical research. And like any complex organism, a trial relies on something vital coursing through it: its lifeblood.

Our ability to combat the spread of fake news in the pharmaceutical industry will shape our future

Our ability to combat the spread of fake news in the pharmaceutical industry will shape our future

Account Director in Public Relations at Langland, Alexandra Walton, reflects on a thought-provoking panel at the PRWeek UK PharmaComms Conference, ‘Disinformation and misinformation – how can pharma communicators fight it?’

Is medical writing entering a new era?

Is medical writing entering a new era?

Annette Keith, Executive Scientific Director at Langland, explores the biggest themes shaping the future of medcomms in a webinar hosted by NetworkPharma.

Clinical trials don’t change fast, but some themes are maturing

Clinical trials don’t change fast, but some themes are maturing

Emily Avent, Senior Account Director in Clinical Trial Experience, highlights her observations from SCOPE Europe 2023.

The AI Roadmap – charting our future in healthcare communications

The AI Roadmap – charting our future in healthcare communications

Elizabeth Mercer, Associate Director, Public Relations & Engagement, contributed to a position paper for the Healthcare Communications Association (HCA) outlining key principles that should guide AI adoption.

Listening to patients when they have something to say, not just when we want an answer

Listening to patients when they have something to say, not just when we want an answer

What makes one person's clinical trial experience better than another's? Strategy Director, Harry Yeates, discusses how capturing feedback from participants while they are in the study could improve communications, site training, and protocol design.

Hey Pharma, who can we trust on social media?

Hey Pharma, who can we trust on social media?

44% of people reportedly consult YouTube before their doctor when seeking treatment for a health condition. Can the information they access be trusted? Emma Robertson, Associate Planning Director, Social Media shares her take.